Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 34398 | 72 | 39.9 | 90% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 600 | 13345 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CDKN3 | Author keyword | 2 | 67% | 3% | 2 |
| 2 | CYCLIN DEPENDENT KINASE ASSOCIATED PROTEIN PHOSPHATASE | Author keyword | 1 | 100% | 3% | 2 |
| 3 | CYTOKINE EXPRESSION PATTERN | Author keyword | 1 | 50% | 1% | 1 |
| 4 | ESOPHAGEAL CARCINOMA CELL LINE | Author keyword | 1 | 50% | 1% | 1 |
| 5 | INSULIN RECEPTOR KINASE IRK | Author keyword | 1 | 50% | 1% | 1 |
| 6 | PROTEIN TYROSINE PHOSPHATASE IB | Author keyword | 1 | 50% | 1% | 1 |
| 7 | RECEPTOR BIOL TUMOUR METASTASIS | Address | 1 | 50% | 1% | 1 |
| 8 | UROL CLIN POLICLIN | Address | 1 | 50% | 1% | 1 |
| 9 | YCR SHEFFIELD CANC | Address | 1 | 50% | 1% | 1 |
| 10 | YEAST HYBRID SYSTEM | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PHOSPHATASE KAP | 4 | 75% | 4% | 3 |
| 2 | KAP | 3 | 35% | 11% | 8 |
| 3 | KINASE ASSOCIATED PHOSPHATASE | 2 | 67% | 3% | 2 |
| 4 | KINASE INHIBITOR 3 | 1 | 100% | 3% | 2 |
| 5 | DECOY OLIGONUCLEOTIDE INHIBITION | 0 | 25% | 1% | 1 |
| 6 | COREPRESSOR KAP 1 | 0 | 17% | 1% | 1 |
| 7 | MITOTIC PATHWAY | 0 | 14% | 1% | 1 |
| 8 | MONONUCLEAR INFLAMMATORY CELLS | 0 | 14% | 1% | 1 |
| 9 | GENOMIC APPROACH | 0 | 13% | 1% | 1 |
| 10 | INTEGRIN ALPHA 5 | 0 | 13% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Extracellular matrix as target for antitumor therapy | 2015 | 1 | 90 | 8% |
| Targeting CDKN3 in cervical cancer | 2014 | 0 | 56 | 16% |
| Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling | 2008 | 34 | 118 | 9% |
| Extracellular matrix and aberrant signaling in lung carcinoma: Role of fibronectin in the control of human lung carcinoma cell growth, apoptosis and resistance to therapy | 2007 | 7 | 125 | 8% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RECEPTOR BIOL TUMOUR METASTASIS | 1 | 50% | 1.4% | 1 |
| 2 | UROL CLIN POLICLIN | 1 | 50% | 1.4% | 1 |
| 3 | YCR SHEFFIELD CANC | 1 | 50% | 1.4% | 1 |
| 4 | CR UK CANC | 0 | 25% | 1.4% | 1 |
| 5 | QUEENS BIOMED | 0 | 14% | 1.4% | 1 |
| 6 | SOCIAL COGNIT BEHAV SCI | 0 | 14% | 1.4% | 1 |
| 7 | DANA FARBER BRIGHAM | 0 | 100% | 1.4% | 1 |
| 8 | VISCERSAL THORAC VASC SURG | 0 | 100% | 1.4% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000126920 | EXTRA DOMAIN A CONTAINING FIBRONECTIN//FIBRONECTIN DOMAINS//RECOMBINANT FIBRONECTIN FRAGMENT |
| 2 | 0.0000111551 | HLTH DISPAR EQU EXPOSOME//EXPOSOME//EPIDEMIOLOGIC PERSPECTIVE |
| 3 | 0.0000105255 | ALKALINE TIDE//HUMAN OSCC//IN VIVO ENVIRONMENT |
| 4 | 0.0000103712 | ALPHA 6 BETA 4 INTEGRIN//INTEGRIN ALPHA 6 BETA 4//CANC BIOL ANGIOGENESIS |
| 5 | 0.0000085851 | LIVER DIS UNIT//CYP 2B1 2//ETHANOL CONTAINING DIET |
| 6 | 0.0000082944 | SPLAYLEG//CONGENITAL SPLAY LEG//DUPLICATION OF RECTUM |
| 7 | 0.0000080085 | DEHYDRON//KINASE TARGETING//ONCOKINOME |
| 8 | 0.0000076053 | PANDER//FAM3B//PANCREATIC DERIVED FACTOR |
| 9 | 0.0000074940 | CAK//CDC2//CYCLIN A1 |
| 10 | 0.0000072316 | FOCAL ADHESION KINASE//FAK//PYK2 |